Pharmacovigilance in hospice/palliative care: net effect of haloperidol for delirium

Alternate title: 
J2 - J Palliat Med
Secondary title: 
T2 - Journal of palliative medicine
Short title: 
Pharmacovigilance in hospice/palliative care: net effect of haloperidol for delirium
Authors: 
Crawford, Gregory B.
Agar M, Meera
Quinn, Stephen J.
Phillips, Jane
Litster, Caroline
Michael, Natasha
Doogue, Matthew
Rowett, Debra
Currow, David C.
Volume: 
16
Start page: 
1335-41
Annotations: 
Type D, Priority 5
Date: 
Nov
Year: 
2013
Accession number: 
24138282
Database: 
MEDLINE Cohort
Number: 
M1 - 11
Serial: 
1557-7740
Type of work: 
M3 - Multicenter Study Research Support, Non-U.S. Gov't
ID: 
12560
DOI: 
http://dx.doi.org/10.1089/jpm.2013.0230
Notes: 
N1 - Crawford GB Agar M M Quinn SJ Phillips J Litster C Michael N Doogue M Rowett D Currow DC
Key words: 
Adult
Aged
Aged, 80 and over
Antipsychotic Agents/ae [Adverse Effects]
*Antipsychotic Agents/tu [Therapeutic Use]
Comorbidity
*Delirium/dt [Drug Therapy]
Female
Haloperidol/ae [Adverse Effects]
*Haloperidol/tu [Therapeutic Use]
*Hospices
Humans
Male
Middle Aged
*Palliative Care
*Pharmacovigilance
Prospective Studies
Questionnaires
Risk Factors
Treatment Outcome
0 (Antipsychotic Agents)
J6292F8L3D (Haloperidol)
Types of evidence: 
Type D
Priorities of Care: 
Priority 5: Plan and do